Canopy Growth Corp (CGC)
About Canopy Growth Corp
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Market cap
- $375.1M
- Gross margin
- 24.5%
- Operating margin
- -56.8%
- Net margin
- -92.4%
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $284.6M
- Cost of revenue
- $214.9M
- Gross profit
- $69.7M
- Operating expenses
- $231.3M
- Operating income
- -$161.7M
- Income tax
- $23.0K
- Net income
- -$262.9M
- EPS (basic)
- $-0.88
- EPS (diluted)
- $-0.88
Balance sheet
- Total assets
- $1.1B
- Current assets
- $529.5M
- Total liabilities
- $421.1M
- Current liabilities
- $158.4M
- Shareholders’ equity
- $697.6M
Cash flow
- Operating cash flow
- -$63.8M
- Investing cash flow
- -$21.3M
- Financing cash flow
- $332.4M
- Net cash flow
- $250.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $375.1M
- EPS (diluted)
- $-0.88
- Dividend yield
- 95.05%
- Shares outstanding
- 371.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 7, 2014
Canopy Growth Corp (CGC) Stock Price
- Revenue declined 45% from FY2022 to FY2026.
- Gross margin of 24.5%, net margin -92.4%.
- Trading 47% below its 52-week high.
- Pays a dividend yielding about 95.05% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Canopy Growth Corp.
Write a review
News about Canopy Growth Corp
News & sentiment via Polygon.io
Canopy Growth Corp: frequently asked questions
Is Canopy Growth Corp an American company?
Canopy Growth Corp is a US-based company headquartered in Smith Falls, A6, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Canopy Growth Corp headquartered?
Canopy Growth Corp is headquartered in Smith Falls, A6, United States.
Is Canopy Growth Corp publicly traded?
Yes — Canopy Growth Corp is a publicly traded company. Its stock trades under the ticker symbol CGC on the NASDAQ.
What does Canopy Growth Corp do?
Canopy Growth Corp is an American Pharmaceuticals company in the Health & Beauty sector.
When was Canopy Growth Corp founded?
Canopy Growth Corp was founded in 2013.
